The progression of hepatorenal syndrome-acute kidney injury in acute alcohol-associated hepatitis: renal outcomes after liver transplant

被引:0
|
作者
Colletta, Alessandro [1 ]
Cooper, Katherine M. [2 ]
Devuni, Deepika [3 ]
机构
[1] UMass Chan Med Sch, 55 Lake Ave North, Worcester, MA 01655 USA
[2] UMass Chan Med Sch, Worcester, MA USA
[3] UMass Chan Med Sch, Div Gastroenterol, Worcester, MA USA
关键词
acute alcohol-associated hepatitis; chronic liver disease; hepatorenal syndrome-acute kidney injury; inflammation; liver transplantation; patient outcomes; renal replacement therapy; CIRRHOSIS; TRANSFUSION; MODEL;
D O I
10.1177/17562848231188813
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Hepatorenal syndrome-acute kidney injury (HRS-AKI) is a complication of advanced liver disease in patients with ascites and circulatory dysfunction. Little data remain on the relationship between HRS-AKI outcomes and different etiologies of liver disease post-liver transplant (LT). Objectives:The primary aim was to evaluate the effect of HRS-AKI on renal outcomes in patients with acute alcohol-associated hepatitis (AAH) compared to chronic liver disease (CLD) after LT. The secondary aim was to evaluate the impact of acuity and chronicity of alcohol-associated liver disease in patients with HRS-AKI post-LT renal outcomes. Design:A retrospective observational study of patients undergoing urgent inpatient liver transplant evaluation (LTE) for cirrhosis and AAH at single academic LT center between October 2017 and July 2021 was conducted. Methods:Patients with HRS-AKI were selected based on indication for LTE: acute AAH(HRS) or CLDHRS. CLDHRS was categorized by disease etiology: cirrhosis due to alcohol (A-CLDHRS) versus cirrhosis from other causes (O-CLDHRS). CLD patients without HRS-AKI were labeled CLDno HRS. Results:A total of 210 subjects underwent LTE; 25% were evaluated for AAH and 75% were evaluated for CLD. Hepatorenal syndrome was more common in subjects evaluated for AAH (37/47) than CLD (104/163) (78.7 versus 63.8%, p = 0.04). For the primary outcome, AAH(HRS) subjects required & GT;30 days post-LT renal replacement therapy (RRT) more often than subjects with CLDHRS (p = 0.02) and CLDno HRS (p < 0.01). There was no significant difference in other forms of long-term renal outcomes including kidney transplant referral and kidney transplant among cohorts. In subgroup analysis, 30-days post-LT RRT was more common in AAH(HRS) than in A-CLDHRS (p = 0.08). Logistic regression showed that AAH(HRS) conferred a 20x and 3.3x odds of requiring & GT;30 days post-LT RRT compared to CLDno HRS and CLDHRS, respectively. Postoperative complications were similar across cohorts, but had a significant effect on 30-day renal outcome post-LT. Conclusions:Patients with AAH were more likely to develop HRS and require RRT pre- and post-LT at our center. The etiology of hepatic decompensation and postoperative complications affect renal recovery post-LT. The systemic inflammation of AAH in addition to conditions favoring renal hypoperfusion may contribute to the unfavorable outcomes of HRS-AKI after LT in this patient population.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] TREATMENT RESPONSE TO TERLIPRESSIN IS UNAFFECTED BY DOSE INTERRUPTIONS IN PATIENTS WITH HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY
    Mumtaz, Khalid
    Bari, Khurram
    Reddy, Gautham
    Regenstein, Fredric
    Zamor, Philippe
    Sass, David
    Jamil, Khurram
    GASTROENTEROLOGY, 2024, 166 (05) : S1581 - S1581
  • [32] OBESITY AND ACUTE ALCOHOL-ASSOCIATED HEPATITIS: ADDING INSULT TO INJURY
    Hsieh, Yun-Cheng
    Babuta, Mrigya
    Siegenberg, Hannah
    Yu, Yunpeng
    Tu, Wanzhu
    Sterling, Richard
    Szabo, Gyongyi
    HEPATOLOGY, 2024, 80
  • [33] Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury
    Agrawal, Jatin
    Kumar, Ashish
    Sharma, Praveen
    Bansal, Naresh
    Singla, Vikas
    Sharma, Samarth
    Arora, Anil
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (01)
  • [34] Selection Criteria for Liver Transplantation for Acute Alcohol-Associated Hepatitis
    Goel, Aparna
    Daugherty, Tami
    CLINICS IN LIVER DISEASE, 2021, 25 (03) : 635 - 644
  • [35] Effect of terlipressin on patients with hepatorenal syndrome, alcohol-associated hepatitis, and acute-on-chronic liver failure grade 0-2
    Moore, Kevin
    Grewal, Priya
    Olivera, Marco
    Bari, Khurram
    Jamil, Khurram
    JOURNAL OF HEPATOLOGY, 2024, 80 : S165 - S166
  • [36] Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression
    Osna, Natalia A.
    Tikhanovich, Irina
    Ortega-Ribera, Marti
    Mueller, Sebastian
    Zheng, Chaowen
    Mueller, Johannes
    Li, Siyuan
    Sakane, Sadatsugu
    Weber, Raquel Carvalho Gontijo
    Kim, Hyun Young
    Lee, Wonseok
    Ganguly, Souradipta
    Kimura, Yusuke
    Liu, Xiao
    Dhar, Debanjan
    Diggle, Karin
    Brenner, David A.
    Kisseleva, Tatiana
    Attal, Neha
    Mckillop, Iain H.
    Chokshi, Shilpa
    Mahato, Ram
    Rasineni, Karuna
    Szabo, Gyongyi
    Kharbanda, Kusum K.
    BIOMOLECULES, 2024, 14 (04)
  • [37] Systemic inflammatory response syndrome and renal resistive index as early predictors of treatment response to terlipressin in hepatorenal syndrome-acute kidney injury
    Narayanan, Vijay
    Chakravorty, Avisek
    Mohapatra, Shivabrata Dhal
    Solanki, Rushil
    Madhu, Devika
    Pal, Ravindra
    Devadas, Krishnadas
    JOURNAL OF HEPATOLOGY, 2022, 77 : S898 - S898
  • [38] Editorial: Solving the acute kidney injury puzzle in alcohol-associated hepatitis-Challenges and insights
    Girish, Vishnu
    Maiwall, Rakhi
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (07) : 963 - 964
  • [39] Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone
    Patidar, Kavish R.
    Tu, Wanzhu
    Cotter, Thomas G.
    Simonetto, Douglas A.
    Asgharpour, Amon
    Jan, Muhammad Y.
    Tang, Qing
    Yu, Yunpeng
    Li, Yang
    Taiwo, Moyinoluwa
    Thevkar Nagesh, Prashanth
    Dasarathy, Srinivasan
    Kamath, Patrick S.
    Mcclain, Craig J.
    Chalasani, Naga
    Szabo, Gyongyi
    Bataller, Ramon
    Mitchell, Mack
    Mehal, Wajahat Z.
    Nagy, Laura E.
    Shah, Vijay H.
    Gawrieh, Samer
    Sanyal, Arun J.
    HEPATOLOGY, 2024,
  • [40] Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
    Guo, Qirui
    Wang, Jie
    Wang, Guangjian
    Wang, Xiaoting
    HEPATOLOGY, 2024, 79 (06) : E161 - E162